The multifunctional role of leukaemia inhibitory factor in cutaneous biology

J C Szepietowski1, A Reich, R C McKenzie

  • 1Department of Dermatology, Venereology and Allergology, University of Medicine, Ul. Chalubinskiego 1, 50-368 Wroclaw, Poland. jszepiet@derm.am.wroc.pl

Insights

Leukaemia Inhibitory Factor (LIF) is a cytokine involved in skin cell differentiation and inflammation. Research suggests LIF plays a role in allergic contact dermatitis, psoriasis, and potentially skin cancer.

Area of Science:

  • Cytokine biology
  • Dermatology
  • Immunology

Background:

  • Leukaemia Inhibitory Factor (LIF) is a pleiotropic cytokine within the hematopoietic growth factor family.
  • It influences growth, differentiation, calcium/bone metabolism, acute phase protein induction, and cachexia in neoplastic disorders.
  • LIF is present in normal skin, potentially aiding keratinocyte differentiation, and is implicated in skin disorder pathogenesis.

Purpose of the Study:

  • To explore the role of Leukaemia Inhibitory Factor (LIF) in skin biology and disease.
  • To investigate LIF's involvement in inflammatory skin conditions like allergic contact dermatitis and psoriasis.
  • To examine potential links between LIF and skin carcinogenesis.

Main Methods:

  • Review of existing medical literature on LIF's functions and roles in skin disorders.
  • Analysis of studies reporting LIF mRNA expression in allergic contact dermatitis.
  • Examination of hypotheses regarding LIF's mechanism in psoriasis, particularly its connection to IL-8.

Main Results:

  • LIF acts as a proinflammatory cytokine.
  • Elevated LIF mRNA expression is observed in allergic contact dermatitis, suggesting early-phase involvement.
  • LIF is important in psoriatic lesions, potentially via IL-8 induction, and may contribute to skin carcinogenesis.

Conclusions:

  • LIF is a significant factor in skin homeostasis and disease.
  • Its proinflammatory properties and role in keratinocyte differentiation highlight its importance in dermatology.
  • Further research is needed to fully elucidate LIF's mechanisms in skin disorders and cancer.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...